Walgreens Boots Alliance, Inc. with ticker code (WBA) now have 14 market analysts covering the stock. The analyst consensus now points to a rating of ‘Hold’. The range between the high target price and low target price is between 54 and 35 suggesting an average Analsyt target price of $40.51. Now with the previous closing price of $35.78 this would indicate that there is a potential upside of 13.2%. It’s also worth noting that there is a 50 day moving average of $35.12 and the 200 moving average now moves to $36.71. The market capitalization for the company is $30,474m. Find out more information at: https://www.walgreensbootsalliance.com
The potential market cap would be $34,503m based on the market consensus.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
The company has a dividend yield of 5.37% with the ex dividend date set at 15-2-2023 (DMY).
